Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity
Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Assuming that genetic variants of the SLC22A2 and SLC31A1 transporter affect patients' susceptibility to cisplatin-induced ototoxicity, we compared the distribution of 11 SLC22A2 variants and the SLC31A1 variant rs10981694 between patients with and without cisplatin-induced ototoxicity.
Genotyping was performed in 64 pediatric patients and signi...
Alternative Titles
Full title
Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4865798
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4865798
Other Identifiers
ISSN
1462-2416
E-ISSN
1744-8042
DOI
10.2217/pgs.14.182
